If you have been following the news lately, you know that GLP-1 medications like semaglutide have fundamentally changed how we treat chronic weight management
BOP cases can involve, among other things, failure to obtain nonresident licenses, scope of practice for midlevel practitioners, inadequate vetting of API, and certificates of analysis
While many anecdotal success stories suggest it can be a valuable tool in a regenerative medicine toolbox, it is still under ongoing investigation
How long is the proposed treatment course, and what are the criteria for stopping
Patients do not self-select their peptides or doses
Always follow medical guidelines and consult with a healthcare professional for personalized recommendations